{"id":17076,"date":"2026-11-04T18:12:08","date_gmt":"2026-11-04T15:12:08","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?page_id=17076"},"modified":"2026-11-04T18:12:08","modified_gmt":"2026-11-04T15:12:08","slug":"english-interaction-abemaciclib-paxlovid-150-mg-100-mg-film-kapli-tablet","status":"publish","type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=17076","title":{"rendered":"Abemaciclib and Paxlovid (Nirmatrelvir\/Ritonavir) (Paxlovid 150 mg\/100 mg Film Kapl\u0131 Tablet): interaction and safety"},"content":{"rendered":"<h2>Interaction mechanism<\/h2>\n<p>Strong CYP3A inhibition may increase anticancer-drug exposure and toxicity.<\/p>\n<h2>Clinical significance and safety<\/h2>\n<p>Abemaciclib with Paxlovid (Nirmatrelvir\/Ritonavir) can increase exposure to the affected anticancer medicine and raise the risk of serious adverse effects. Strong CYP3A inhibitors should be avoided where possible. If the combination is necessary, the oncology team must plan the medicine-specific interruption or dose modification and close toxicity monitoring. Do not change the doses yourself.<\/p>\n<h2>Using this information<\/h2>\n<p>This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abemaciclib with Paxlovid (Nirmatrelvir\/Ritonavir) can increase exposure to the affected anticancer medicine and raise the risk of serious adverse effects. Strong CYP3A inhibi\u2026<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-17076","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages\/17076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17076"}],"version-history":[{"count":0,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages\/17076\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}